US Regulator and CME Engage in Heated Dispute Over On-Chain Perpetual Futures

The conflict between the CME Group, the largest derivatives exchange operator in the US, and the Commodity Futures Trading Commission (CFTC) has escalated into a full-blown dispute. At the center of the issue is the CFTC's decision to allow the listing of blockchain-based perpetual futures products, which the CME claims are not in line with current regulations. The CME has filed a lawsuit against the CFTC, arguing that these products are essentially swaps, requiring an end date and specific obligations, rather than traditional futures contracts. The CFTC, on the other hand, views these products as a new type of futures contract that can be traded 24/7, allowing for greater flexibility and innovation in the market. The outcome of this dispute is expected to have significant implications for the US approach to the rapidly growing market of perpetual futures, with potential consequences for both the CME and the broader financial industry. The CME's lawsuit challenges the CFTC's decision to approve the listing of crypto perpetual futures by Kalshi and Coinbase, arguing that the regulator has mislabeled these products and failed to consider their potential impact on the market. The CFTC, however, believes that its approach will foster innovation and competition in the market, while the CME sees it as a threat to its traditional business model. As the dispute unfolds, market participants and observers are watching closely, with some arguing that the CME's stance is motivated by a desire to protect its dominance in the market, while others see the CFTC's approach as a necessary step towards embracing new technologies and innovations. The future of perpetual futures in the US remains uncertain, with the outcome of the CME's lawsuit and the CFTC's regulatory approach hanging in the balance.